A Zoladex purchase can fail before shipment if the buyer names only “goserelin injection,” accepts an unclear substitute, or overlooks destination-country import rules. By the end, you will know how to describe the required product, test an exporter’s documents, calculate the delivery responsibility, and receive a traceable shipment.
Key takeaways
- Specify goserelin strength, depot form, pack size, quantity and destination.
- Confirm whether you need branded Zoladex or a licensed generic implant.
- Request the exporter’s licence, batch documents and traceability records.
- Check import approval and cold-chain delivery requirements before payment.
Start with a complete product request, not a product nickname
Send a complete request: “Zoladex LA 10.8 mg, goserelin acetate, biodegradable depot implant in a prefilled syringe, subcutaneous dosage form, [pack size], [required quantity], destination [country], delivery required by [date].” State whether you require branded Zoladex or a licensed generic goserelin implant.
1. Ask the Zoladex exporter to confirm the offered brand or generic status, manufacturer, available batch, expiry date, remaining shelf life at dispatch, cartons per shipment, minimum order quantity, dispatch lead time, labelled storage condition, transport controls, and permitted substitution policy. Do not accept a different strength, presentation, or generic without written approval.
2. Require a pro-forma invoice before issuing the purchase order. It must separate medicine price, freight, insurance, duties, and other charges, and show the currency, payment terms, Incoterm, minimum order quantity, dispatch lead time, storage requirements, and documents supplied.
3. Follow the transaction in order: inquiry, pro-forma invoice, purchase order, payment, dispatch, export customs, destination customs clearance, and final delivery. The quotation must name the party responsible for export customs, import declaration, duties, permits, and customs holds. Confirm the destination country allows the 10.8 mg implant and the requested brand or generic before paying.
This format lets you compare landed cost, timing, customs responsibility, and usable shelf life—not just a unit price—when assessing a zoladex exporter.
Confirm the exact depot presentation before approving the quotation
10.8 mg must mean the long-acting goserelin depot, generally administered at a 12-week interval—not three 3.6 mg implants, which are generally used at 28-day intervals. Ask the seller whether the quotation covers branded Zoladex or a licensed generic product before you compare prices.
1. Put the exact item in the purchase order: brand or generic name, goserelin acetate, marketing-authorisation holder, manufacturer, country of origin, dosage form, strength, pack size, and destination-market registration number.
2. Reject any substitution unless you approve it in writing and confirm that the destination country permits that brand, generic, strength, and presentation. A generic goserelin implant is not Zoladex merely because it contains the same active ingredient.
3. Request clear photographs of the actual pack showing the brand, goserelin acetate, strength, prefilled-syringe or implant presentation, manufacturer, batch number, expiry date, regulatory wording, and barcode.
The pack must identify a biodegradable subcutaneous implant in a prefilled syringe, not a conventional vial labelled only “goserelin injection.” A search for a zoladex 10 point 8 mg supplier or goserelin injection exporter must therefore exclude a vial, a different strength, and an unregistered generic.
Match the photograph, quotation, purchase order, and destination-market record before authorising payment.
Test the exporter’s authority and batch traceability
An Indian Importer-Exporter Code (IEC) proves an export-trade identity, not approval to sell a medicine for clinical use in your country. Ask the Zoladex anti cancer medicine exporter to identify the legal exporting entity and provide:
1. Indian drug-manufacturing permission or loan-licence details, where applicable; product registration evidence; the IEC; and the manufacturer’s name and address. Confirm whether the offer is branded Zoladex or a licensed generic goserelin implant.
2. Batch documents for the quoted stock: commercial invoice, packing list, certificate of origin, transport document, customs information, batch-specific certificate of analysis or certificate of conformity, and batch-release or quality records.
3. A quality file covering identity, assay, sterility, implant appearance or dimensions, and relevant prefilled-syringe or applicator attributes. A generic company certificate or an untraceable COA does not establish batch traceability.
4. Matching details across the pack, invoice, certificates and regulatory record. Check the manufacturer, marketing-authorisation holder, lot number and expiry date on every document. Reject unexplained differences.
5. The complaint contact, pharmacovigilance contact, recall procedure and chain-of-custody record from manufacturer to exporter, carrier and receiving site. For NIBA HEALTHCARE or any other supplier, apply these checks rather than trusting a page title or company certificate.
Do not release payment until the exporter links the actual 10.8 mg sterile implant to these records. A document that names only “goserelin” cannot prove that the shipment is the requested product, lawful in your market, or suitable for clinical use.
Related product
![]() | Goserelin Acetate Injection Zoladex LA 10.8mg Injection is given as an injection under the skin by a qualified medical professional. View product → |
Clear the destination-country requirements before paying
An Indian export licence authorises export from India; it does not authorise import or sale in your country. Before paying, a goserelin medicine importer must confirm that the destination permits the 10.8 mg strength, biodegradable implant in a prefilled syringe, intended indication, and proposed branded or generic status.
1. Verify the importer’s licence, prescription-medicine registration, prior import authorisation, customs classification, controlled-product procedure, local-language labelling, minimum remaining shelf life, and requirement for a local regulatory representative.
2. In Brazil, confirm the importing company’s health-authority permissions and the product’s Anvisa status or lawful import route before accepting a commercial shipment. The route differs for a registered product, patient-use import, institutional supply, and exceptional access.
3. Put responsibility in writing before payment. Identify who files the import declaration, provides the customs classification, pays duties, obtains any destination import permit, requests any required Indian export authorisation, and resolves a customs hold.
4. Ask the exporter to state the exact labelled storage condition, transport controls, and excursion procedure. Zoladex depot products are commonly labelled for controlled room temperature below 25°C and protection from freezing, not routine 2–8°C storage, but the market-specific pack controls the decision.
5. Obtain the destination regulator’s answer in writing when registration or import status is unclear. A shipment that clears Indian export checks can still be detained, refused, relabelled, or barred from clinical sale at destination.
Inspect delivery records and protect the clinical chain of custody
At receipt, quarantine the shipment until the receiving team reconciles the transport document, dispatch date, carton count and delivery date. Obtain the shipping temperature record when the market or label requires it; if a limit was breached, demand the excursion report and apply the agreed procedure for damaged, delayed or rejected goods.
Compare every carton with the purchase order and approved photographs before releasing stock.
| Check | Delivered item must match | Record |
|---|---|---|
| Product | Brand or generic name, goserelin acetate, 10.8 mg, implant in a prefilled syringe | Product name, presentation and quantity |
| Manufacturer | Manufacturer and marketing-authorisation details shown on the approved order | Manufacturer and country where required |
| Batch | Batch number and expiry date | Lot, expiry and remaining shelf life |
| Compliance | Destination-market regulatory label and barcode | Label version and registration details |
| Packaging | Seals, cartons, applicators and tamper evidence intact | Damage, looseness, punctures or missing evidence |
Store the medicine according to the exact market label, including its stated maximum temperature and protection from freezing. Do not place it in a 2–8°C vaccine chain unless the label or a regulatory instruction requires that condition.
Keep the invoice, packing list, certificate of analysis, batch-release record, certificate of origin, customs documents and receiving inspection together for recall tracing. Distribution must include approved prescribing information covering the initial hormone surge, tumour flare, glucose control, cardiovascular or QT risks, bone loss, pregnancy and trained clinical administration.
Frequently asked questions
What details should a Zoladex order request include?
State the product name, goserelin acetate, strength such as 10.8 mg, biodegradable depot implant format, prefilled syringe, pack size, quantity, destination country and required delivery date. Also identify whether you require branded Zoladex or a licensed generic.
How do you confirm the exact Zoladex depot presentation?
Check the strength, release interval, dosage form, prefilled-syringe format, implant description and pack configuration on the quotation and product documents. Do not approve a quotation that states only “goserelin injection” or “Zoladex.”
What should you request from a Zoladex exporter?
Ask for the exporter’s pharmaceutical licence or authorisation, manufacturer details, batch number, expiry date, certificate of analysis, certificate of pharmaceutical product when required, and documents linking the offered batch to the shipment.
What must a goserelin medicine importer check before paying?
Confirm the destination country’s import licence, prescription-medicine rules, product registration or named-patient pathway, required health-authority documents, customs requirements and any temperature-controlled transport conditions.
How should you protect the clinical chain of custody during delivery?
Agree the shipping temperature range, packaging, temperature-monitoring evidence, delivery handover, seal inspection, batch recording and procedure for rejected or damaged cartons before dispatch.
